Feasibility of classical secondary hormonal therapies prior to docetaxel therapy in Japanese patients with castration-resistant prostate cancer: Multicenter retrospective study

Feasibility of classical secondary hormonal therapies prior to docetaxel therapy in Japanese patients with castration-resistant prostate cancer: Multicenter retrospective study

Background: We retrospectively analyzed castration-resistant prostate cancer (CRPC) patients treated with secondary hormonal therapies (SHTs) prior to docetaxel therapy. Methods: The cases of 73 CRPC patients who underwent docetaxel therapy in 2005–2011 at four hospitals in Ibaraki, Japan were analy...

Full description

Bibliographic Details
Main Authors: Shuya Kandori, Takayuki Yoshino, Masakazu Tsutsumi, Atsushi Yamauchi, Mikinobu Ohtani, Yoshiharu Fukuhara, Naoto Miyanaga, Jun Miyazaki, Hiroyuki Nishiyama, Toru Shimazui
Format: Article
Language:English
Published: Elsevier 2016-12-01
Series:Prostate International
Subjects:
Castration-resistant prostate cancer
Cause-specific survival
Docetaxel
Secondary hormonal therapies
Online Access:http://www.sciencedirect.com/science/article/pii/S2287888216300423

Internet

http://www.sciencedirect.com/science/article/pii/S2287888216300423

Similar Items